2014 Rheumatology Highlights From Boston*

November 15-19, 2014; Boston, Massachusetts
Review highlights from the 2014 Boston rheumatology meeting in CCO’s Independent Conference Coverage, which includes clinical commentary, a Conference Report with embedded slides, and a downloadable slideset.


The 2014 American College of Rheumatology annual meeting provided us with new and promising data on the safety and efficacy of current and investigational agents. How soon will we have new treatment options for patients with PsA?

Released: February 6, 2015

Research presented at the 2014 ACR annual meeting showed that targeting the IL-23/IL-17 axis in ankylosing spondylitis led to high ASAS20 responses, and the use of TNF inhibitors benefits patients with nonradiographic axial spondyloarthritis.

Released: February 6, 2015

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?